Regenerative medicine: a 2009 overview

The rapidly evolving field of regenerative medicine holds much promise for cell‐based therapies for a range of debilitating conditions from spinal cord injury to haematological and neurological diseases. The groundbreaking discovery of induced pluripotent stem (iPS) cells has offered new perspectives on disease progression and the possibility of patient‐specific cell transplants. In this review we first give a brief history of the field of regenerative medicine and then discuss the current state of regenerative medicine with a focus on embryonic stem cells and iPS cells. In order to keep abreast with this rapidly developing field, the Journal of Internal Medicine organized a 2‐day Symposium, on March 12–13th 2009, at the Karolinska Insitute in Stockholm, which featured talks by 19 leading scientists in the field of regenerative medicine. In this review, we discuss the Symposium and introduce six accompanying review articles, by Symposium speakers, which focus on some of the topics discussed at the meeting.

[1]  A. Dhawan,et al.  Human hepatocyte transplantation: state of the art , 2009, Journal of internal medicine.

[2]  T. Perlmann,et al.  Neuronal cell replacement in Parkinson’s disease , 2009, Journal of internal medicine.

[3]  M. Sigvardsson,et al.  New light on the biology and developmental potential of haematopoietic stem cells and progenitor cells , 2009, Journal of internal medicine.

[4]  S. Tajbakhsh Skeletal muscle stem cells in developmental versus regenerative myogenesis , 2009, Journal of internal medicine.

[5]  W. Richter,et al.  Mesenchymal stem cells and cartilage in situ regeneration , 2009, Journal of internal medicine.

[6]  Jake A. Kushner,et al.  Cellular origins of β‐cell regeneration: a legacy view of historical controversies , 2009, Journal of internal medicine.

[7]  Mike J. Mason,et al.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. , 2009, Cell stem cell.

[8]  A. Björklund,et al.  Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells , 2009, Proceedings of the National Academy of Sciences.

[9]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[10]  B. Lowry Faculty Opinions recommendation of Human induced pluripotent stem cells free of vector and transgene sequences. , 2009 .

[11]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[12]  Marcos J. Araúzo-Bravo,et al.  Oct4-Induced Pluripotency in Adult Neural Stem Cells , 2009, Cell.

[13]  Gideon Rechavi,et al.  Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient , 2009, PLoS medicine.

[14]  A. Gratwohl,et al.  The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies , 2009, Bone Marrow Transplantation.

[15]  K. Eggan,et al.  Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. , 2008, Cell stem cell.

[16]  Jennifer Nichols,et al.  Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition , 2008, PLoS biology.

[17]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[18]  Hynek Wichterle,et al.  Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.

[19]  Takashi Aoi,et al.  Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells , 2008, Science.

[20]  T. Mikkelsen,et al.  Dissecting direct reprogramming through integrative genomic analysis , 2008, Nature.

[21]  M. Araúzo-Bravo,et al.  Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors , 2008, Nature.

[22]  K. Brennand,et al.  Reprogramming of Pancreatic β Cells into Induced Pluripotent Stem Cells , 2008, Current Biology.

[23]  R. Hauser,et al.  Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.

[24]  Marius Wernig,et al.  Direct Reprogramming of Terminally Differentiated Mature B Lymphocytes to Pluripotency , 2008, Cell.

[25]  R. Jaenisch,et al.  Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease , 2008, Proceedings of the National Academy of Sciences.

[26]  Elisabet Englund,et al.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.

[27]  Marius Wernig,et al.  c-Myc is dispensable for direct reprogramming of mouse fibroblasts. , 2008, Cell stem cell.

[28]  George Q. Daley,et al.  Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.

[29]  Marius Wernig,et al.  Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin , 2007, Science.

[30]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[31]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[32]  G. Gahrton,et al.  High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future. , 2007, Seminars in hematology.

[33]  M. Ramalho-Santos,et al.  Generation of induced pluripotent stem cells in the absence of drug selection. , 2007, Cell stem cell.

[34]  Marius Wernig,et al.  Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells , 2007, Nature Biotechnology.

[35]  R. Jaenisch,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2007, Nature.

[36]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[37]  M. Trotter,et al.  Derivation of pluripotent epiblast stem cells from mammalian embryos , 2007, Nature.

[38]  R. McKay,et al.  New cell lines from mouse epiblast share defining features with human embryonic stem cells , 2007, Nature.

[39]  J. Utikal,et al.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. , 2007, Cell stem cell.

[40]  Yunfu Sun,et al.  Multipotent Embryonic Isl1 + Progenitor Cells Lead to Cardiac, Smooth Muscle, and Endothelial Cell Diversification , 2006, Cell.

[41]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[42]  Lina A. Thoren,et al.  Identification of Flt3+ Lympho-Myeloid Stem Cells Lacking Erythro-Megakaryocytic Potential A Revised Road Map for Adult Blood Lineage Commitment , 2005, Cell.

[43]  V. Tabar,et al.  Derivation of midbrain dopamine neurons from human embryonic stem cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Wichterle,et al.  Directed Differentiation of Embryonic Stem Cells into Motor Neurons , 2002, Cell.

[45]  R. McKay,et al.  Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic Islets , 2001, Science.

[46]  R. Gatti,et al.  Successful marrow transplantation for correction of immunological deficit in lymphopenic agammaglobulinemia and treatment of immunologically induced pancytopenia. Reprinted from Experimental Hematology 1969; 11:-10. , 2001, Journal of hematotherapy & stem cell research.

[47]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[48]  I. Wilmut,et al.  Viable offspring derived from fetal and adult mammalian cells , 1997, Nature.

[49]  Edwin Clarke,et al.  Cajal's Degeneration and regeneration of the nervous system , 1992, Medical History.

[50]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[51]  H. Green,et al.  Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is , 1975, Cell.

[52]  H. Green,et al.  Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma , 1975, Cell.

[53]  J. Till,et al.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. , 1961, Radiation research.

[54]  A. Scheibel,et al.  Degeneration and regeneration of the nervous system , 1960 .

[55]  T. Elsdale,et al.  Sexually Mature Individuals of Xenopus laevis from the Transplantation of Single Somatic Nuclei , 1958, Nature.

[56]  World's first clinical trial of human embryonic stem cell therapy cleared. , 2009, Regenerative medicine.

[57]  Takashi Aoi,et al.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.

[58]  T. Ichisaka,et al.  GENERATION OF GERMLINECOMPETENT INDUCED PLURIPOTENT STEM CELLS , 2007 .

[59]  I. Weissman,et al.  Hematopoietic stem cells , 2006, Stem Cell Reviews.

[60]  C. Feistritzer,et al.  Signal Transduction (1930 articles) , 2001 .

[61]  H Green,et al.  Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. , 1975, Cell.